Piekos Brian

Chief Financial Officer at KALV

Sold, on record
$165k
Dollars the filings state
Form 4 sales
4
Latest May 22, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • KALVKalVista Pharmaceuticals, Inc.Chief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
3
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale KALVUnusual
    Nov 24 2025

    Sold 4,471 shares at $13.45 ($60k)

    Piekos Brian, Chief Financial Officer

    No 10b5-1 planSold 29.8% of holdings ($202k position)10,529 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale KALVNo plan
    Feb 23 +91 days

    Sold 1,767 shares at $15.57 ($28k)

    Piekos Brian, Chief Financial Officer

    No 10b5-1 planSold 11.4% of holdings ($242k position)13,762 shares leftFiling

  3. 3 Form 4 sale KALVNo plan
    Apr 17 +53 days

    Sold 1,862 shares at $20.22 ($38k)

    Piekos Brian, Chief Financial Officer

    No 10b5-1 planSold 9.3% of holdings ($405k position)18,150 shares leftFiling

  4. 4 Form 4 sale KALVNo plan
    May 22 +35 days

    Sold 1,489 shares at $26.78 ($40k)

    Piekos Brian, Chief Financial Officer

    No 10b5-1 planSold 6.4% of holdings ($620k position)21,661 shares left0.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Piekos Brian
Source
May 22, 2026KALVChief Financial OfficerForm 4 sale1,489$40k6.4%No planSEC
Apr 17, 2026KALVChief Financial OfficerForm 4 sale1,862$38k9.3%No planSEC
Feb 23, 2026KALVChief Financial OfficerForm 4 sale1,767$28k11.4%No planSEC
Nov 24, 2025KALVChief Financial OfficerForm 4 sale4,471$60k29.8%UnusualSEC